Manuel Montero, MD
Nephrology · New Bern, NCNPI 1114929346
Payments from drug & device makers
Across 1,907 payments — averaging $1301.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$953K
- Akebia Therapeutics Inc$355K
- Novo Nordisk AS$329K
- Fresenius USA Marketing, Inc.$286K
- AstraZeneca$143K
- Bayer$94K
- plus $322K from 23 others
Across 2 payments — averaging $731.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 11 | $953,396 |
| Akebia Therapeutics Inc | 418 | $355,164 |
| Novo Nordisk AS | 1,193 | $328,740 |
| Fresenius USA Marketing, Inc. | 19 | $286,009 |
| AstraZeneca(2 entities) | 26 | $143,488 |
| Bayer | 84 | $93,804 |
| Astrazeneca UK Limited | 4 | $72,195 |
| Travere Therapeutics, Inc. | 37 | $67,494 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $67,014 |
| Sanofi US Services Inc. | 14 | $45,496 |
| Eli Lilly | 1 | $28,658 |
| Aurinia Pharma U.S., Inc. | 9 | $20,972 |
| CSL Behring | 6 | $16,271 |
| Lexicon Pharmaceuticals, Inc. | 1 | $1,127 |
| Nxstage Medical, Inc. | 9 | $580 |
| Amgen(2 entities) | 25 | $517 |
| Merck | 1 | $500 |
| Otsuka America Pharmaceutical, Inc. | 11 | $225 |
| Vifor Pharma, Inc. | 7 | $115 |
| GSK | 6 | $105 |
| Novartis | 5 | $99 |
| Ardelyx, Inc. | 3 | $61 |
| Calliditas Therapeutics US Inc. | 2 | $56 |
| Daiichi Sankyo Inc. | 3 | $50 |
| OPKO Pharmaceuticals, LLC | 2 | $39 |
| Novo Nordisk | 2 | $35 |
| Sanofi | 2 | $32 |
| Boehringer Ingelheim | 2 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
How this compares
$2,482,295 in reported general payments places this provider in the 95th percentile of 366 nephrology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in New Bern
- Stuart JenningsNew Bern$40K
- Daniel EdmonstonDurham$9.9M
- Gregory GreenwoodWinston-Salem$4.1M
- Barry FreedmanWinston Salem$3.5M
- Rekha JohnKinston$2.3M
- Nauman ShahidGreenville$2M
- Eric KirkWilmington$1.7M
- Amy MottlSanford$1.6M
- Amarnath KathresalDurham$1.6M
- Koithara Varkey ThomasJacksonville$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.